Predicting Psychotic Relapse Using Speech-Based Early Detection

ConditionPsychosis
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age16+
SponsorDouglas Mental Health University Institute

About this trial

Psychotic disorders, including schizophrenia and affective psychosis, are severe mental health conditions marked by recurrent episodes that contribute to long-term disability. Relapses, characterized by the re-emergence of psychotic symptoms after remission, are a critical factor in the progression of these disorders, increasing risks such as suicide, cognitive impairment, and unemployment. This study aims to develop a novel, speech-based digital model to predict relapses in individuals with psychosis. Building on previous research into language abnormalities in schizophrenia, the study will employ a longitudinal design across Early Psychosis Intervention (EPI) clinics in Ontario and Quebec to advance relapse prediction

Eligibility criteria

Qualifiers

Age must be 16 years and older

Diagnosis must meet DSM-5 criteria for psychotic disorders, including schizophrenia, schizoaffective disorder, or related conditions

Fluency in English or French

Must be currently receiving treatment through an EPI program

Disqualifiers

Severe comorbid speech or language disorders (e.g., aphasia)

Primary diagnosis of non-psychotic disorders

Inability to provide consent or complete assessments

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

250 Participants
are grouped into 1 trial group